Phagolum Ltd. is developing a diagnostic toolkit to detect sepsis, the leading cause of death in non-coronary ICU patients and the tenth most common cause of death overall. According to medical literature, “sepsis is characterized by a whole-body inflammatory state caused by infection” and is “broadly defined as the presence of various pus-forming and other …
Continue reading “ATI Invests $2M in Phagolum Sepsis Diagnostic Toolkit”
Undergraduate students from the Technion Institute of Technology have invented a novel, non-invasive device “to detect respiratory problems at an early stage in premature babies, children and adults in intensive care units (ICU)”, according to the Jerusalem Post. The students created the device as part of an undergraduate project suggested by Professor Amir Landesberg and …
Continue reading “Students Invent Early-Detection Medical Device”
Professor Avraham Hochberg from the Hebrew University is the Chief Scientist of Biocancell, a two-year-old Israeli biotech startup specializing in the development of patient-oriented, targeted therapy for the treatment of a wide range of cancers. Biocancell was created with former Yissum President and CEO Avi Barak to develop and market Hochberg’s potentially revolutionary cancer treatment. …
Continue reading “Potentially Groundbreaking Cancer Treatment Needs Money”
Given Imaging’s new PillCam COLON was not approved for commercial distribution by the FDA on February 18, even though it’s been approved for commercial use in Israel and Europe. The Israeli company develops, produces and markets innovative, patient-friendly products that detect gastrointestinal disorders. The PillCam COLON is a new product based on the PillCam Platform. …
SCPVitalife Fund is a new Israel venture capital capital that has just raised a whole lot of money to invest in Israel’s promising biomed startups. Jeff Dykan, Managing Director of the fund said they “planned to raise $150 million but the fund is already oversubscribed at $162 million,” and that they may end up turning …
Continue reading “New Fund Raises $162M to Invest In 17 Israel BioMed Companies”
